You are here

Article info

Article menu

Download PDFPDF

Editorial
Myo-inositol for insulin resistance, metabolic syndrome, polycystic ovary syndrome and gestational diabetes

Authors

  • James J DiNicolantonio Department of Preventive Cardiology, Saint Lukes Mid America Heart Institute, University of Missouri–Kansas City, Kansas City, Missouri, USA PubMed articlesGoogle scholar articles
  • James H O'Keefe Department of Preventive Cardiology, Saint Lukes Mid America Heart Institute, University of Missouri–Kansas City, Kansas City, Missouri, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr James J DiNicolantonio; jjdinicol{at}gmail.com
View Full Text

Citation

DiNicolantonio JJ, H O'Keefe J
Myo-inositol for insulin resistance, metabolic syndrome, polycystic ovary syndrome and gestational diabetes
Open Heart 2022;9:e001989. doi: 10.1136/openhrt-2022-001989

Publication history

  • Accepted February 16, 2022
  • First published March 2, 2022.
Online issue publication 
March 06, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.